Skip to main content
NCBI home page
Gut logoLink to Gut
. 1987 Nov;28(11):1460–1466. doi: 10.1136/gut.28.11.1460

Absence of complement fixing antibodies against lipopolysaccharides from Escherichia coli in a subgroup of patients with Crohn's disease.

M Zeitz 1, U Hope 1, B Wust 1, C Galanos 1, B Möller 1, T J Lawley 1, E O Riecken 1
PMCID: PMC1433671  PMID: 3322954

Abstract

Complement fixing antibodies against different Escherichia coli lipopolysaccharides were determined in patients with Crohn's disease and in healthy individuals and compared with antitetanus toxoid antibodies. All healthy individuals had antilipopolysaccharide antibodies, 10 of 27 patients with Crohn's disease had no antibodies and six had rapidly changing antibody titres. These abnormalities were found in patients with disease in the colon, with arthropathy and fistula. Antilipid A was found at lower titres in Crohn's disease. Neither antitetanus toxoid antibodies, nor immunoglobulin concentrations were different in patients with or without antilipopolysaccharide antibodies. There was no evidence for circulating immune complexes in patients lacking antilipopolysaccharide antibodies. Certain subgroups of patients with Crohn's disease have altered antibody levels to typical enteral antigens which most likely can be explained by local antibody binding to lipopolysaccharides at inflammatory sites, or by changes in immunoregulation in this disease.

Full text

PDF
1460

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Best W. R., Becktel J. M., Singleton J. W., Kern F., Jr Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology. 1976 Mar;70(3):439–444. [PubMed] [Google Scholar]
  2. Blaser M. J., Miller R. A., Lacher J., Singleton J. W. Patients with active Crohn's disease have elevated serum antibodies to antigens of seven enteric bacterial pathogens. Gastroenterology. 1984 Oct;87(4):888–894. [PubMed] [Google Scholar]
  3. Fiocchi C., Battisto J. R., Farmer R. G. Studies on isolated gut mucosal lymphocytes in inflammatory bowel disease. Detection of activated T cells and enhanced proliferation to Staphylococcus aureus and lipopolysaccharides. Dig Dis Sci. 1981 Aug;26(8):728–736. doi: 10.1007/BF01316863. [DOI] [PubMed] [Google Scholar]
  4. Hobbiss J., Cooper K. M., Moore M., Gowland E., Schofield P. F. Limitations of immune complex measurements in colorectal disease. Br J Surg. 1983 Aug;70(8):473–477. doi: 10.1002/bjs.1800700808. [DOI] [PubMed] [Google Scholar]
  5. Hodgson H. J., Potter B. J., Jewell D. P. Immune complexes in ulcerative colitis and Crohn's disease. Clin Exp Immunol. 1977 Aug;29(2):187–196. [PMC free article] [PubMed] [Google Scholar]
  6. James S. P., Neckers L. M., Graeff A. S., Cossman J., Balch C. M., Strober W. Suppression of immunoglobulin synthesis by lymphocyte subpopulations in patients with Crohn's disease. Gastroenterology. 1984 Jun;86(6):1510–1518. [PubMed] [Google Scholar]
  7. KUNIN C. M. SEPARATION, CHARACTERIZATION, AND BIOLOGICAL SIGNIFICANCE OF A COMMON ANTIGEN IN ENTEROBACTERIACEAE. J Exp Med. 1963 Oct 1;118:565–586. doi: 10.1084/jem.118.4.565. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Kemler B. J., Alpert E. Inflammatory bowel disease associated circulating immune complexes. Gut. 1980 Mar;21(3):195–201. doi: 10.1136/gut.21.3.195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Kruis W., Schussler P., Weinzierl M., Galanos C., Eisenburg J. Circulating lipid A antibodies despite absence of systemic endotoxemia in patients with Crohn's disease. Dig Dis Sci. 1984 Jun;29(6):502–507. doi: 10.1007/BF01296269. [DOI] [PubMed] [Google Scholar]
  10. Lawley T. J., Moutsopoulos H. M., Katz S. I., Theofilopoulos A. N., Chused T. M., Frank M. M. Demonstration of circulating immune complexes in Sjögren's syndrome. J Immunol. 1979 Sep;123(3):1382–1387. [PubMed] [Google Scholar]
  11. Lum L. G., Culbertson N. J. The induction and suppression of in vitro IgG anti-tetanus toxoid antibody synthesis by human lymphocytes stimulated with tetanus toxoid in the absence of in vivo booster immunizations. J Immunol. 1985 Jul;135(1):185–191. [PubMed] [Google Scholar]
  12. Mancini G., Carbonara A. O., Heremans J. F. Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry. 1965 Sep;2(3):235–254. doi: 10.1016/0019-2791(65)90004-2. [DOI] [PubMed] [Google Scholar]
  13. Perlmann P., Hammarström S., Lagercrantz R., Campbell D. Autoantibodies to colon in rats and human ulcerative colitis: cross reactivity with Escherichia coli O:14 antigen. Proc Soc Exp Biol Med. 1967 Jul;125(3):975–980. doi: 10.3181/00379727-125-32253. [DOI] [PubMed] [Google Scholar]
  14. Schüssler P., Kruis W., Marget W. Lipoid-A-Antikörpertiter bei Morbus Crohn. Klin Wochenschr. 1976 Nov 1;54(21):1055–1056. doi: 10.1007/BF01469251. [DOI] [PubMed] [Google Scholar]
  15. Sieber G., Herrmann F., Zeitz M., Teichmann H., Rühl H. Abnormalities of B-cell activation and immunoregulation in patients with Crohn's disease. Gut. 1984 Nov;25(11):1255–1261. doi: 10.1136/gut.25.11.1255. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Stevens R., Oliver M., Brogan M., Heiserodt J., Targan S. Defective generation of tetanus-specific antibody-producing B cells after in vivo immunization of Crohn's disease and ulcerative colitis patients. Gastroenterology. 1985 Jun;88(6):1860–1866. doi: 10.1016/0016-5085(85)90011-3. [DOI] [PubMed] [Google Scholar]
  17. Tabaqchali S., O'Donoghue D. P., Bettelheim K. A. Escherichia coli antibodies in patients with inflammatory bowel disease. Gut. 1978 Feb;19(2):108–113. doi: 10.1136/gut.19.2.108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Thayer W. R., Jr, Brown M., Sangree M. H., Katz J., Hersh T. Escherichia Coli O:14 and colon hemagglutinating antibodies in inflammatory bowel disease. Gastroenterology. 1969 Sep;57(3):311–318. [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES